A case of primary malignant melanoma of the esophagus and analysis of 193 patients in Japan

Japanese Journal of Gastroenterology

Volumn 101, Issue 10, 2004, Pages 1087-1094

  Yamaguchi, Tomohiro ^b   Shioaki, Yasuhiro ^b   Koide, Kazuma ^b   Kurioka, Hideaki ^a   Nobutani, Kentaro ^b   Funatsu, Eiji ^b   Kutsumi, Hiromu ^b   Fujimoto, Sotaro ^a   Hosokawa, Yohei ^a  

^a KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; DACARBAZINE; DOXORUBICIN; NIMUSTINE; TAMOXIFEN; VINCRISTINE; VINCRISTINE SULFATE;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; DISEASE COURSE; ESOPHAGUS CANCER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA;

AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; FEMALE; HUMANS; MELANOMA; PROGNOSIS;

EID: 7044263172     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lewin KJ, Appelman HD: Tumors of the Esophagus and Stomach (Atlas of Tumor Pathology), 3rd Series, Vol. 18, American Registry of Pathology, Washington DC. 1996:166-170
2. Gastroenterol Endosc 1994; 36: 2422-2431
3. Chalkiadakis G, Wihlm JM, Morand G, et al: Primary malignant melanoma of the esophagus. Ann Thorac Surg 1985; 39: 472-475
4. Sabanathan S, Eng J, Pradhan GN: Primary malignant melanoma of the esophagus. Am J Gastroenterol 1989; 84: 1475-1481
5. Gastroenterol Endosc 1985; 31: 2670-2675
6. Allen AC, Spittz S: Malignant melanoma. A clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 1953; 6: 1-45
7. Mukaiya M, Hirata K, Tarumi K, et al: Surgical treatment for recurrent tumors of primary malignant melanoma of the esophagus: a case report and review of the literature. Hepatogastroenterology 1999; 46: 295-298
8. Joob AW, Haines GK III, Kies MS, et al: Primary malignant melanoma of the esophagus. Ann Thorac Surg 1995; 60: 217-222
9. Lam KY, Law S, Wong J: Malignant melanoma of the oesophagus: clinicopathological features, lack of p53 expression and steroid receptors and a review of the literature. Eur J Surg Oncol 1999; 25: 168-172
10. Lohmann CM, Hwu WJ, Iversen K, et al: Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens. Melanoma Res 2003; 13: 595-601
11. Volpin E, Sauvanet A, Belghiti J, et al: Primary malignant melanoma of the esophagus: a case report and review of the literature. Dis Esophagus 2002; 15: 244-249
12. Adili F, Monig SP: Surgical therapy of primary malignant melanoma of the esophagus. Ann Thorac Surg 1997; 63: 1461-1463
13. Guermazi A, Rili M, Fritsch S, et al: Primary malignant melanoma of the esophagus. Ann Chir 2000; 125: 985-988
14. Turnbull AD, Rosen P, Goddner JT, et al: Primary tumors of the esophagus other than atypical epidermoid carcinoma. Ann Thorac Surg 1973; 15: 463-473
15. Hamdy FC, Smith JH, Kennedy A, et al: Long survival after excision of a primary malignant melanoma of the esophagus. Thorax 1991; 46: 397-398
16. Kato H, Watanabe H, Tachimori Y, et al: Primary malignant melanoma of the esophagus: report of four cases. Jpn J Clin Oncol 1991; 21: 306-313
17. Sakamoto H, Uedo N, Ishiguro S, et al: Treatment of primary malignant melanoma of the esophagus with endoscopic injection of interferon-β combined with systemic chemotherapy: a case report. Gastrointest Endosc 2003; 57: 773-777
18. Salvatore A, Maurer LH, Joseph O, et al: Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. Cancer Treat Rep 1984; 68: 1403-1405
19. Maclay EF, Mastrangelo MJ, Sprandio JD, et al: The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma. Cancer 1989; 63: 1292-1295
20. Ruth O, Ronald HB: Chemotherapy for malignant melanoma. Adv Oncol 1994; 10: 26-29
21. Naomoto Y, Perdomo JA, Tanaka N, et al: Primary malignant melanoma of the esophagus: report of a case successfully treated with pre-and post-operative adjuvant hormone-chemotherapy. Jpn J Clin Oncol 1998;28:758-761